Talis Biomedical Corporation Operating Lease Liability
Talis Biomedical Corporation had Operating Lease Liability of $18.80 million as of 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2024-08-19
- 2024-06-30: Operating Lease, Liability $18.80M.
- 2024-03-31: Operating Lease, Liability $19.24M.
- 2023-12-31: Operating Lease, Liability $19.67M.
- 2023-09-30: Operating Lease, Liability $20.08M.
| Period end | Operating Lease, Liability |
|---|---|
| 2024-06-30 | $18.80M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $19.24M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $19.67M 10-K · filed 2024-03-28 |
| 2023-09-30 | $20.08M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $20.39M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $14.71M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $33.58M 10-K · filed 2023-03-22 |
| 2022-09-30 | $33.33M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $33.10M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $14.15M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $13.98M 10-K · filed 2022-03-15 |
| 2021-09-30 | $14.09M 10-Q · filed 2021-11-16 |
| 2021-06-30 | $14.06M 10-Q · filed 2021-08-10 |